RecruitingNot ApplicableNCT07134192

Fluorescence-Guided Optimization of Sarcoma Margins


Sponsor

University of Aarhus

Enrollment

90 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a special fluorescent dye visible under a specific light (similar to technology used in detecting cancer margins) to help surgeons better identify and remove all of the tumor tissue during sarcoma surgery. The goal is to reduce the chance of leaving cancer cells behind. **You may be eligible if...** - You are over 18 years old - You have a confirmed intermediate-to-high grade sarcoma (a type of soft tissue or bone cancer) located on a limb or the trunk wall - Your tumor can be surgically removed with intent to cure - You have consented to participate **You may NOT be eligible if...** - You have a history of allergic reactions to iodine-containing substances - You have end-stage kidney disease or very low kidney function (eGFR below 15) - You have decided not to participate or cannot give informed consent - Your tumor is not operable Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREFluorescent-guided Surgery

Surgical treatment of the patient group will include the administration of a fluorescent dye and intraoperatively the resection will be aided and guided by the fluorescent signal. The wound bed will be inspected, areas with fluorescent signal will be excised and obtained separately for histopathology. Patients will receive the current post-operative standard of care for sarcoma patients


Locations(2)

Aarhus University Hospital

Aarhus N, Denmark

Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07134192


Related Trials